Epigral Ltd
As of 16 Oct 2026, Epigral is in Stage 3 — topping, where an uptrend loses steam, in its first week (since 12 Oct 2026). It closed at ₹996, 42.0% below its 52-week high and below its 200-day average, which is falling. In Materials, 34.1% of stocks are in Stage 2.
Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is EPIGRAL early, or has it already run? Pro answers that for every NSE stock, after every close.
About this companyMaterials· Commodity Chemicals
Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India.
Visit company website →All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.